Open bottle of prescription PrEP Pills for Pre-Exposure Prophylaxis to help protect people from HIV. We find ourselves in a particularly challenging stage of the pandemic. While proving to be ...
A recent study published in JAMA Network Open evaluated the cost-effectiveness of monoclonal antibodies (mAbs) as pre-exposure prophylaxis (PrEP) for coronavirus disease 2019 (COVID-19). Study: Health ...
Dr Milgram focuses on the cost-effectiveness of cabotegravir as a long-acting injectable PrEP therapy and how providers and payers use data and real-world evidence to create PrEP policies.
Please provide your email address to receive an email when new articles are posted on . More than 40 years ago, on June 5, 1981, a report of five cases of Pneumocystis pneumonia among young men in Los ...
June 17, 2022 – Many male couples in the U.S. seem to be underestimating the effectiveness of HIV pre-exposure prophylaxis (PrEP) for HIV prevention, and educating partners together could improve the ...
A new analysis of 2014-2018 data among all states plus Washington, DC, for those who have either indications for preexposure prophylaxis (PrEP) or current prescriptions for the preventive treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results